Access Now: Equitymaster's Premium Small Cap Research at 50% Off
Here is the latest financial fact sheet of JENBURKT PH.. For more details, see the JENBURKT PH. quarterly results and JENBURKT PH. share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.3 |
No. of shares | m | 4.41 |
1 Week | % | 0.3 |
1 Month | % | 9.1 |
1 Year | % | 37.0 |
52 week H/L | Rs | 800.0/452.1 |
No. of Mths Year Ending |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
5-Yr Chart Click to enlarge
|
---|
JENBURKT PH. EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 683 | 880 | 560 | 500 | 700 | |
Low | Rs | 392 | 452 | 243 | 298 | 391 | |
Sales per share (Unadj.) | Rs | 249.1 | 267.2 | 259.0 | 238.1 | 270.1 | |
Earnings per share (Unadj.) | Rs | 37.5 | 43.1 | 32.4 | 36.0 | 48.6 | |
Diluted earnings per share | Rs | 39.0 | 44.9 | 33.7 | 37.4 | 50.5 | |
Cash flow per share (Unadj.) | Rs | 40.8 | 46.1 | 37.4 | 40.4 | 52.7 | |
Dividends per share (Unadj.) | Rs | 9.00 | 10.20 | 8.10 | 10.20 | 12.00 | |
Adj. dividends per share | Rs | 9.36 | 10.61 | 8.42 | 10.61 | 12.48 | |
Avg Dividend yield | % | 1.7 | 1.5 | 2.0 | 2.6 | 2.2 | |
Book value per share (Unadj.) | Rs | 133.5 | 168.8 | 174.3 | 214.5 | 255.7 | |
Adj. book value per share | Rs | 138.8 | 175.5 | 181.3 | 223.1 | 266.0 | |
Shares outstanding (eoy) | m | 4.59 | 4.59 | 4.59 | 4.59 | 4.59 | |
Price / Sales ratio | x | 2.2 | 2.5 | 1.6 | 1.7 | 2.0 | |
Avg P/E ratio | x | 14.3 | 15.4 | 12.4 | 11.1 | 11.2 | |
P/CF ratio (eoy) | x | 13.2 | 14.4 | 10.7 | 9.9 | 10.3 | |
Price / Book Value ratio | x | 4.0 | 3.9 | 2.3 | 1.9 | 2.1 | |
Dividend payout | % | 24.0 | 23.6 | 25.0 | 28.4 | 24.7 | |
Avg Mkt Cap | Rs m | 2,466 | 3,056 | 1,843 | 1,831 | 2,503 | |
Total wages/salary | Rs m | 277 | 312 | 365 | 324 | 365 |
JENBURKT PH. INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,144 | 1,226 | 1,189 | 1,093 | 1,240 | |
Other income | Rs m | 34 | 34 | 42 | 43 | 49 | |
Total revenues | Rs m | 1,178 | 1,261 | 1,231 | 1,136 | 1,289 | |
Gross profit | Rs m | 238 | 249 | 197 | 198 | 273 | |
Depreciation | Rs m | 15 | 14 | 23 | 20 | 19 | |
Interest | Rs m | 4 | 4 | 5 | 5 | 4 | |
Profit before tax | Rs m | 253 | 266 | 211 | 216 | 299 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 81 | 68 | 63 | 51 | 76 | |
Profit after tax | Rs m | 172 | 198 | 149 | 165 | 223 | |
Gross profit margin | % | 20.8 | 20.3 | 16.6 | 18.2 | 22.0 | |
Effective tax rate | % | 31.9 | 25.7 | 29.7 | 23.7 | 25.4 | |
Net profit margin | % | 15.1 | 16.1 | 12.5 | 15.1 | 18.0 |
JENBURKT PH. BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 660 | 898 | 896 | 800 | 759 | |
Current liabilities | Rs m | 132 | 254 | 199 | 180 | 213 | |
Net working cap to sales | % | 46.2 | 52.4 | 58.7 | 56.7 | 44.1 | |
Current ratio | x | 5.0 | 3.5 | 4.5 | 4.4 | 3.6 | |
Inventory Days | Days | 18 | 17 | 14 | 99 | 162 | |
Debtors Days | Days | 400 | 681 | 547 | 468 | 448 | |
Net fixed assets | Rs m | 116 | 128 | 148 | 405 | 667 | |
Share capital | Rs m | 46 | 46 | 46 | 46 | 46 | |
"Free" reserves | Rs m | 567 | 729 | 754 | 939 | 1,128 | |
Net worth | Rs m | 613 | 775 | 800 | 985 | 1,174 | |
Long term debt | Rs m | 2 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 776 | 1,025 | 1,044 | 1,204 | 1,426 | |
Interest coverage | x | 62.3 | 70.0 | 41.2 | 46.7 | 69.8 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.5 | 1.2 | 1.1 | 0.9 | 0.9 | |
Return on assets | % | 22.7 | 19.7 | 14.7 | 14.1 | 15.9 | |
Return on equity | % | 28.1 | 25.6 | 18.6 | 16.8 | 19.0 | |
Return on capital | % | 41.8 | 34.9 | 27.1 | 22.5 | 25.8 | |
Exports to sales | % | 12.3 | 14.3 | 12.7 | 19.6 | 17.0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 140 | 175 | 151 | 214 | 210 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 140 | 175 | 151 | 214 | 210 | |
Fx outflow | Rs m | 23 | 26 | 23 | 31 | 28 | |
Net fx | Rs m | 118 | 149 | 128 | 183 | 183 |
JENBURKT PH. CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 162 | 130 | 150 | 195 | 94 | |
From Investments | Rs m | 10 | -105 | -29 | -188 | -13 | |
From Financial Activity | Rs m | -180 | -24 | -108 | -7 | -55 | |
Net Cashflow | Rs m | -8 | 0 | 13 | -0 | 25 |
Share Holding
Shareholding as on Mar 2023
|
Company Information
|
CHM: Ashish U Bhuta | COMP SEC: Ashish R Shah | YEAR OF INC: 1985 | BSE CODE: 524731 | FV (Rs): 10 | DIV YIELD (%): 1.6 |
More Pharmaceuticals Company Fact Sheets: AUROBINDO PHARMA CIPLA PIRAMAL ENTERPRISES ZYDUS LIFESCIENCES LUPIN
Compare JENBURKT PH. With: AUROBINDO PHARMA CIPLA PIRAMAL ENTERPRISES ZYDUS LIFESCIENCES LUPIN
After opening the day flat, Indian share markets picked up pace as session progressed and ended the day higher.